144 related articles for article (PubMed ID: 36801622)
1. Cancers attributable to infectious agents in Italy.
Collatuzzo G; La Vecchia C; Parazzini F; Alicandro G; Turati F; Di Maso M; Malvezzi M; Pelucchi C; Negri E; Boffetta P
Eur J Cancer; 2023 Apr; 183():69-78. PubMed ID: 36801622
[TBL] [Abstract][Full Text] [Related]
2. Estimates of the incidence of infection-related cancers in Italy and Italian regions in 2018.
DE Flora S; LA Maestra S; Crocetti E; Mangone L; Bianconi F; Stracci F; Buzzoni C
J Prev Med Hyg; 2019 Dec; 60(4):E311-E326. PubMed ID: 31967088
[TBL] [Abstract][Full Text] [Related]
3. Cancers Attributable to Infections in the US in 2017: A Meta-Analysis.
Volesky-Avellaneda KD; Morais S; Walter SD; O'Brien TR; Hildesheim A; Engels EA; El-Zein M; Franco EL
JAMA Oncol; 2023 Dec; 9(12):1678-1687. PubMed ID: 37856141
[TBL] [Abstract][Full Text] [Related]
4. Estimation of Cancer Burden Attributable to Infection in Asia.
Huang H; Hu XF; Zhao FH; Garland SM; Bhatla N; Qiao YL
J Epidemiol; 2015; 25(10):626-38. PubMed ID: 26399446
[TBL] [Abstract][Full Text] [Related]
5. Incidence of infection-associated cancers in Italy and prevention strategies.
De Flora S; Crocetti E; Bonanni P; Ferro A; Vitale F;
Epidemiol Prev; 2015; 39(4 Suppl 1):14-20. PubMed ID: 26499410
[TBL] [Abstract][Full Text] [Related]
6. Viral infections and cancer: epidemiological aspects.
Serraino D; Piselli P; Scognamiglio P
J Biol Regul Homeost Agents; 2001; 15(3):224-8. PubMed ID: 11693428
[TBL] [Abstract][Full Text] [Related]
7. Cancers attributable to infections in Canada.
Volesky KD; El-Zein M; Franco EL; Brenner DR; Friedenreich CM; Ruan Y;
Prev Med; 2019 May; 122():109-117. PubMed ID: 31078164
[TBL] [Abstract][Full Text] [Related]
8. Estimates of the future burden of cancer attributable to infections in Canada.
Volesky KD; El-Zein M; Franco EL; Brenner DR; Friedenreich CM; Ruan Y;
Prev Med; 2019 May; 122():118-127. PubMed ID: 31078165
[TBL] [Abstract][Full Text] [Related]
9. Racial/Ethnic Differences in Cancers Attributable to Preventable Infectious Agents in Texas, 2015.
Gudenkauf FJ; Thrift AP
Public Health Rep; 2020; 135(6):805-812. PubMed ID: 33080142
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of Epstein-Barr virus, hepatitis B virus, hepatitis C virus, and human immunodeficiency virus among patients with non-Hodgkin's lymphoma at the Yaounde General Hospital, Cameroon.
Bikoï JN; Ndedi EDFM; Okobalemba EA; Mbaga DS; Mikangue CAM; Membangbi AE; Nguiffo EM; Essindi JO; Mondinde GI; Essama SHR
Pan Afr Med J; 2022; 42():58. PubMed ID: 35949454
[TBL] [Abstract][Full Text] [Related]
11. Cancers in Australia in 2010 attributable to infectious agents.
Antonsson A; Wilson LF; Kendall BJ; Bain CJ; Whiteman DC; Neale RE
Aust N Z J Public Health; 2015 Oct; 39(5):446-51. PubMed ID: 26437730
[TBL] [Abstract][Full Text] [Related]
12. Population attributable fraction of infection-related cancers in Korea.
Shin A; Park S; Shin HR; Park EH; Park SK; Oh JK; Lim MK; Choi BY; Boniol M; Boffetta P
Ann Oncol; 2011 Jun; 22(6):1435-1442. PubMed ID: 20974652
[TBL] [Abstract][Full Text] [Related]
13. Estimates of Cancer Mortality Attributable to Carcinogenic Infections in Italy.
Ferrara P; Conti S; Agüero F; Albano L; Masuet-Aumatell C; Ramon-Torrell JM; Mantovani LG
Int J Environ Res Public Health; 2020 Nov; 17(23):. PubMed ID: 33255366
[TBL] [Abstract][Full Text] [Related]
14. The cancer burden attributable to biologic agents.
Schottenfeld D; Beebe-Dimmer J
Ann Epidemiol; 2015 Mar; 25(3):183-7. PubMed ID: 25523895
[TBL] [Abstract][Full Text] [Related]
15. The global health burden of infection-associated cancers in the year 2002.
Parkin DM
Int J Cancer; 2006 Jun; 118(12):3030-44. PubMed ID: 16404738
[TBL] [Abstract][Full Text] [Related]
16. Cancer in Africa 2018: The role of infections.
Parkin DM; Hämmerl L; Ferlay J; Kantelhardt EJ
Int J Cancer; 2020 Apr; 146(8):2089-2103. PubMed ID: 31254479
[TBL] [Abstract][Full Text] [Related]
17. Presence of human papillomavirus and Epstein-Barr virus in the cervix of women infected with the human immunodeficiency virus.
Ammatuna P; Giovannelli L; Giambelluca D; Mancuso S; Rubino E; Colletti P; Mazzola G; Belfiore P; Lima R
J Med Virol; 2000 Dec; 62(4):410-5. PubMed ID: 11074467
[TBL] [Abstract][Full Text] [Related]
18. Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment.
Chen W; Xia C; Zheng R; Zhou M; Lin C; Zeng H; Zhang S; Wang L; Yang Z; Sun K; Li H; Brown MD; Islami F; Bray F; Jemal A; He J
Lancet Glob Health; 2019 Feb; 7(2):e257-e269. PubMed ID: 30683243
[TBL] [Abstract][Full Text] [Related]
19. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
[TBL] [Abstract][Full Text] [Related]
20. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013.
Degenhardt L; Charlson F; Stanaway J; Larney S; Alexander LT; Hickman M; Cowie B; Hall WD; Strang J; Whiteford H; Vos T
Lancet Infect Dis; 2016 Dec; 16(12):1385-1398. PubMed ID: 27665254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]